Meningococcal Vaccines Market

Publisher Grand View Research

Published Jan 28, 2026

Length 150 Pages

SKU # GV20873288

Description

Meningococcal Vaccines Market Summary

The global meningococcal vaccines market size was estimated at USD 4.05 billion in 2025 and is projected to reach USD 5.96 billion by 2033, growing at a CAGR of 4.5% from 2026 to 2033. The increasing prevalence of meningitis is one of the major factors expected to drive the market.

According to the Centers for Disease Control and Prevention (CDC), approximately 1.2 million cases of bacterial meningitis are projected worldwide each year. Moreover, expanding immunization programs, greater awareness of the disease, and increased R&D activities for meningococcal vaccines are expected to fuel market growth during the forecast period.

Meningococcal vaccines are critical tools in preventing invasive Neisseria meningitidis infections, which can cause life-threatening meningitis and sepsis. These vaccines target the serogroups most responsible for disease-A, B, C, W, and Y-through distinct formulations, including quadrivalent (MenACWY), serogroup B (MenB), and pentavalent (MenABCWY). As of 2025, regulatory agencies have expanded approvals to improve coverage across age groups, with MenQuadfi licensed for individuals from six weeks of age to provide protection against serogroups A, C, W, and Y. Routine recommendations by public health authorities continue to emphasize adolescent immunization as foundational to disease control. For instance, in July 2025, CDC guidance reinforced the importance of routine vaccination for adolescents and at-risk individuals.

Market and regulatory developments in 2024-2025 reflect a strategic shift toward broader protective vaccines that simplify immunization schedules and enhance uptake. Pentavalent vaccines such as Pfizer’s Penbraya and GSK’s Penmenvy, each covering serogroups A, B, C, W, and Y, have received approval for use in individuals aged 10-25 years, consolidating protection previously provided by multiple vaccines. In April 2025, ACIP recommended using pentavalent vaccines when both MenACWY and MenB immunizations are indicated during the same clinical visit, streamlining delivery protocols. For instance, in April 2025, a federal advisory committee recommended pentavalent meningococcal vaccines to support broader, integrated vaccination approaches.

Public health guidance and vaccine uptake efforts remain focused on balancing broad protection with targeted risk-based strategies. In 2024, the FDA updated dosing schedules for MenB vaccines, such as Bexsero, to optimize immunogenicity in recommended cohorts, underscoring evolving evidence and refinements to dosing schedules. Concurrently, efforts in lower-income settings, such as the 2024 rollout of WHO-recommended five-strain vaccines in parts of Africa, illustrate the global imperative to extend meningococcal prevention beyond high-income markets. Continuing enhancements in vaccine access and policy aim to reduce the burden of meningococcal disease globally through age-appropriate immunization.

Global Meningococcal Vaccines Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global meningococcal vaccines market report based on type, brand, serotype, age group, sales channel, and region:

Type Outlook (Revenue, USD Million, 2021 - 2033)
Bivalent
Quadrivalent
Others
Brand Outlook (Revenue, USD Million, 2021 - 2033)
Menactra
Menveo
Nimenrix
Trumenba
Bexsero
Others
Serotype Outlook (Revenue, USD Million, 2021 - 2033)
A
B
C
W-135
Y
Age Group Outlook (Revenue, USD Million, 2021 - 2033)
Infants (0 to 2 years)
Children and Adults (2 years and above)
Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
Private
Public
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.2. Research Methodology; 1.3. Information Procurement; 1.3.1. Purchased database; 1.3.2. GVR’s internal database; 1.3.3. Secondary sources; 1.3.4. Primary research; 1.4. Information or Data Analysis; 1.4.1. Data analysis models; 1.5. Market Formulation & Data Validation; 1.6. Model Details; 1.6.1. Commodity flow analysis (Model 1); 1.6.2. Approach 1: Commodity flow approach; 1.6.3. Volume price analysis (Model 2); 1.6.4. Approach 2: Volume price analysis; 1.7. List of Secondary Sources; 1.8. List of Primary Sources; 1.9. Objectives
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Component outlook; 2.2.2. Application outlook; 2.2.3. Technology outlook; 2.2.4. End Use outlook; 2.2.5. Regional outlook; 2.3. Competitive Insights
Chapter 3. Artificial Intelligence in Healthcare Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent market outlook; 3.1.2. Related/ancillary market outlook; 3.2. Market Dynamics; 3.2.1. Market driver analysis; 3.2.2. Market restraint analysis; 3.2.3. Market opportunity analysis; 3.2.4. Market challenges analysis; 3.3. Case Studies Insights; 3.4. Artificial Intelligence in Healthcare Market Analysis Tools; 3.4.1. Industry Analysis - Porter’s; 3.4.1.1. Supplier power; 3.4.1.2. Buyer power; 3.4.1.3. Substitution threat; 3.4.1.4. Threat of new entrant; 3.4.1.5. Competitive rivalry; 3.4.2. PESTEL Analysis; 3.4.2.1. Political landscape; 3.4.2.2. Technological landscape; 3.4.2.3. Economic landscape; 3.4.2.4. Environmental Landscape; 3.4.2.5. Legal Landscape; 3.4.2.6. Social Landscape
Chapter 4. Artificial Intelligence in Healthcare Market: Component Estimates & Trend Analysis: 4.1. Definitions and Scope; 4.2. Segment Dashboard; 4.3. Artificial Intelligence in Healthcare Market Movement Analysis; 4.4. Artificial Intelligence in Healthcare Market Size & Trend Analysis,; 4.4.1. Software Solutions; 4.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.1.1.1. AI platform; 4.4.1.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.1.1.1.2. Application Program Interface (API); 4.4.1.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.1.1.1.3. Machine Learning Framework; 4.4.1.1.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.1.1.2. AI Solutions; 4.4.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.1.1.2.2. On premise; 4.4.1.1.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.1.1.2.3. Cloud based; 4.4.1.1.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2. Hardware; 4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.1. Processor; 4.4.2.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.1.2. MPU (memory protection unit); 4.4.2.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.1.3. FPGA (Field-programmable gate array); 4.4.2.1.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.1.4. GPU (Graphics processing unit); 4.4.2.1.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.1.5. ASIC (Application-specific integrated circuit); 4.4.2.1.1.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.2. Memory; 4.4.2.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.3. Network; 4.4.2.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.3.2. Adapter; 4.4.2.1.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.3.3. Interconnect; 4.4.2.1.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.2.1.3.4. Switch; 4.4.2.1.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.3. Services; 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.3.1.1. Deployment & Integration; 4.4.3.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.3.1.2. Support & Maintenance; 4.4.3.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 4.4.3.1.3. Others (Consulting, Compliance management, etc.); 4.4.3.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Artificial Intelligence in Healthcare Market: Application Estimates & Trend Analysis: 5.1. Definitions and Scope; 5.2. Segment Dashboard; 5.3. Artificial Intelligence in Healthcare Market Movement Analysis; 5.4. Artificial Intelligence in Healthcare Market Size & Trend Analyses, by Application, 2021 to 2033 (USD Million); 5.4.1. Robot-Assisted Surgery; 5.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.2. Virtual Assistants; 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.3. Administrative Workflow Assistants; 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.4. Connected Medical Devices; 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.5. Medical Imaging & Diagnosis; 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.6. Clinical Trials; 5.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.7. Fraud Detection; 5.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.8. Cybersecurity; 5.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.9. Dosage Error Reduction; 5.4.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.10. Precision medicine; 5.4.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.11. Drug discovery & development; 5.4.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.12. Lifestyle management & remote patient monitoring; 5.4.12.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.13. Wearables; 5.4.13.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 5.4.14. Others; 5.4.14.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Artificial Intelligence in Healthcare Market: Technology Estimates & Trend Analysis: 6.1. Definitions and Scope; 6.2. Segment Dashboard; 6.3. Artificial Intelligence in Healthcare Market Movement Analysis; 6.4. Artificial Intelligence in Healthcare Market Size & Trend Analyses, by Technology, 2021 to 2033 (USD Million); 6.4.1. Machine Learning; 6.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million); 6.4.1.1.1. Deep learning; 6.4.1.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.1.1.2. Supervised; 6.4.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.1.1.3. Unsupervised; 6.4.1.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.1.1.4. Others (Reinforcement learning, Semi-supervised); 6.4.1.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.2. NLP; 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD million); 6.4.2.1.1. Smart Assistance; 6.4.2.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.2.1.2. OCR (Optical Character Recognition); 6.4.2.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.2.1.3. Auto Coding; 6.4.2.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.2.1.4. Text analytics; 6.4.2.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.2.1.5. Speech analytics; 6.4.2.1.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.2.1.6. Classification and categorization; 6.4.2.1.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 6.4.3. Computer Vision; 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD million); 6.4.4. Context-aware computing; 6.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD million)
Chapter 7. Artificial Intelligence in Healthcare Market: End Use Estimates & Trend Analysis: 7.1. Definitions and Scope; 7.2. Segment Dashboard; 7.3. Artificial Intelligence in Healthcare Market Movement Analysis; 7.4. Artificial Intelligence in Healthcare Market Size & Trend Analyses, By End Use, 2021 to 2033 (USD Million); 7.4.1. Healthcare providers (hospitals, outpatient facilities, and others); 7.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million); 7.4.2. Healthcare payers; 7.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 7.4.3. Healthcare Companies; 7.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 7.4.4. Patients; 7.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 7.4.5. Others; 7.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Artificial Intelligence in Healthcare Market: Regional Estimates & Trend Analysis by Component, Applications, Technology & End Use: 8.1. Regional Market Dashboard; 8.2. Global Regional Market Snapshot; 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033; 8.4. North America; 8.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 8.4.2. U.S.; 8.4.2.1. U.S. market estimates and forecast, 2021 - 2033 (USD Million); 8.4.3. Canada; 8.4.3.1. Canada market estimates and forecast, 2021 - 2033 (USD Million); 8.4.4. Mexico; 8.4.4.1. Mexico market estimates and forecast, 2021 - 2033 (USD Million); 8.5. Europe; 8.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 8.5.2. UK; 8.5.2.1. UK market estimates and forecast, 2021 - 2033 (USD Million); 8.5.3. Germany; 8.5.3.1. Germany market estimates and forecast, 2021 - 2033 (USD Million); 8.5.4. France; 8.5.4.1. France market estimates and forecast, 2021 - 2033 (USD Million); 8.5.5. Italy; 8.5.5.1. Italy market estimates and forecast, 2021 - 2033 (USD Million); 8.5.6. Spain; 8.5.6.1. Spain market estimates and forecast, 2021 - 2033 (USD Million); 8.5.7. Sweden; 8.5.7.1. Sweden market estimates and forecast, 2021 - 2033 (USD Million); 8.5.8. Denmark; 8.5.8.1. Denmark market estimates and forecast, 2021 - 2033 (USD Million); 8.5.9. Norway; 8.5.9.1. Norway market estimates and forecast, 2021 - 2033 (USD Million); 8.6. Asia Pacific; 8.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 8.6.2. Japan; 8.6.2.1. Japan market estimates and forecast, 2021 - 2033 (USD Million); 8.6.3. China; 8.6.3.1. China market estimates and forecast, 2021 - 2033 (USD Million); 8.6.4. India; 8.6.4.1. India market estimates and forecast, 2021 - 2033 (USD Million); 8.6.5. Australia; 8.6.5.1. Australia market estimates and forecast, 2021 - 2033 (USD Million); 8.6.6. South Korea; 8.6.6.1. South Korea market estimates and forecast, 2021 - 2033 (USD Million); 8.6.7. Thailand; 8.6.7.1. Thailand market estimates and forecast, 2021 - 2033 (USD Million); 8.6.8. South Korea; 8.6.8.1. South Korea market estimates and forecast, 2021 - 2033 (USD Million); 8.7. Latin America; 8.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 8.7.2. Brazil; 8.7.2.1. Brazil market estimates and forecast, 2021 - 2033 (USD Million); 8.7.3. Argentina; 8.7.3.1. Argentina market estimates and forecast, 2021 - 2033 (USD Million); 8.8. MEA; 8.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million); 8.8.2. South Africa; 8.8.2.1. South Africa market estimates and forecast, 2021 - 2033 (USD Million); 8.8.3. Saudi Arabia; 8.8.3.1. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million); 8.8.4. UAE; 8.8.4.1. UAE market estimates and forecast, 2021 - 2033 (USD Million); 8.8.5. Kuwait; 8.8.5.1. UAE market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape: 9.1. Recent Developments & Impact Analysis, By Key Market Participants; 9.2. Company/Competition Categorization; 9.2.1. Key Innovators; 9.2.2. Market Leaders; 9.2.3. Emerging Players; 9.3. Vendor Landscape; 9.3.1. Key company market share analysis, 2025; 9.3.2. Microsoft; 9.3.2.1. Company overview; 9.3.2.2. Financial performance; 9.3.2.3. Product benchmarking; 9.3.2.4. Strategic initiatives; 9.3.3. IBM; 9.3.3.1. Company overview; 9.3.3.2. Financial performance; 9.3.3.3. Product benchmarking; 9.3.3.4. Strategic initiatives; 9.3.4. NVIDIA Corporation; 9.3.4.1. Company overview; 9.3.4.2. Financial performance; 9.3.4.3. Product benchmarking; 9.3.4.4. Strategic initiatives; 9.3.5. Intel Corporation; 9.3.5.1. Company overview; 9.3.5.2. Financial performance; 9.3.5.3. Product benchmarking; 9.3.5.4. Strategic initiatives; 9.3.6. Itrex Group; 9.3.6.1. Company overview; 9.3.6.2. Financial performance; 9.3.6.3. Product benchmarking; 9.3.6.4. Strategic initiatives; 9.3.7. GE Healthcare; 9.3.7.1. Company overview; 9.3.7.2. Financial performance; 9.3.7.3. Product benchmarking; 9.3.7.4. Strategic initiatives; 9.3.8. Medtronic; 9.3.8.1. Company overview; 9.3.8.2. Financial performance; 9.3.8.3. Product benchmarking; 9.3.8.4. Strategic initiatives; 9.3.9. Oracle; 9.3.9.1. Company overview; 9.3.9.2. Financial performance; 9.3.9.3. Product benchmarking; 9.3.9.4. Strategic initiatives; 9.3.10. Medidata; 9.3.10.1. Company overview; 9.3.10.2. Financial performance; 9.3.10.3. Product benchmarking; 9.3.10.4. Strategic initiatives; 9.3.11. Google; 9.3.11.1. Company overview; 9.3.11.2. Financial performance; 9.3.11.3. Product benchmarking; 9.3.11.4. Strategic initiatives; 9.3.12. Merck; 9.3.12.1. Company overview; 9.3.12.2. Financial performance; 9.3.12.3. Product benchmarking; 9.3.12.4. Strategic initiatives; 9.3.13. IQVIA; 9.3.13.1. Company overview; 9.3.13.2. Financial performance; 9.3.13.3. Product benchmarking; 9.3.13.4. Strategic initiatives

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi User License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now